Sabra Healthcare REIT (NASDAQ:SBRA) Share Price Passes Above Two Hundred Day Moving Average - Should You Sell?

Key Points

• Sabra Healthcare REIT shares briefly moved above their 200-day moving average, reaching $20.42 before last trading at $20.15. Analysts have a “Moderate Buy” consensus and an average price target of $22.23.
• The company reported a quarterly earnings miss of $0.10 per share versus the $0.17 consensus estimate, although revenue of $230.11 million exceeded expectations and rose 24.7% year over year.
• Sabra maintains a quarterly dividend of $0.30, equivalent to a 6.0% annualized yield, but its 461.54% payout ratio is notably high. CEO Richard Matros also sold 200,000 shares under a pre-arranged trading plan.

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Get Free Report)'s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $20.20 and traded as high as $20.42. Sabra Healthcare REIT shares last traded at $20.15, with a volume of 2,011,622 shares traded.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on SBRA. Truist Financial boosted their target price on shares of Sabra Healthcare REIT from $22.00 to $24.00 and gave the company a "buy" rating in a research note on Wednesday, July 22nd. Weiss Ratings cut shares of Sabra Healthcare REIT from a "buy (b)" rating to a "hold (c+)" rating in a research note on Tuesday, August 4th. Wells Fargo & Company lifted their price target on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an "overweight" rating in a report on Monday, June 1st. Deutsche Bank Aktiengesellschaft reissued a "buy" rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Finally, Raymond James Financial raised shares of Sabra Healthcare REIT from an "underperform" rating to a "market perform" rating in a research note on Thursday, August 6th. Seven research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $22.23.

Sabra Healthcare REIT Price Performance

The stock has a market capitalization of $5.15 billion, a price-to-earnings ratio of 77.50, a price-to-earnings-growth ratio of 1.52 and a beta of 0.65. The company has a 50 day moving average of $20.73 and a 200 day moving average of $20.20. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.95.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.27). The business had revenue of $230.11 million for the quarter, compared to analysts' expectations of $219.39 million. Sabra Healthcare REIT had a return on equity of 2.34% and a net margin of 7.61%.The business's quarterly revenue was up 24.7% compared to the same quarter last year. During the same quarter last year, the company posted $0.38 earnings per share. As a group, equities research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.52 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, August 31st. Investors of record on Friday, August 14th were given a $0.30 dividend. The ex-dividend date of this dividend was Friday, August 14th. This represents a $1.20 annualized dividend and a dividend yield of 6.0%. Sabra Healthcare REIT's dividend payout ratio (DPR) is currently 461.54%.

Insider Transactions at Sabra Healthcare REIT

In related news, CEO Richard Matros sold 200,000 shares of the business's stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total value of $4,166,000.00. Following the completion of the sale, the chief executive officer directly owned 1,657,686 shares in the company, valued at approximately $34,529,599.38. The trade was a 10.77% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.09% of the company's stock.

Hedge Funds Weigh In On Sabra Healthcare REIT

A number of large investors have recently bought and sold shares of the stock. Anchor Investment Management LLC boosted its holdings in shares of Sabra Healthcare REIT by 17.8% in the 2nd quarter. Anchor Investment Management LLC now owns 4,877 shares of the real estate investment trust's stock valued at $95,000 after purchasing an additional 737 shares during the last quarter. Core Capital Management & Research inc. purchased a new stake in shares of Sabra Healthcare REIT during the 2nd quarter valued at $204,000. Tidal Investments LLC increased its holdings in shares of Sabra Healthcare REIT by 204.1% during the 2nd quarter. Tidal Investments LLC now owns 37,958 shares of the real estate investment trust's stock worth $741,000 after buying an additional 25,477 shares during the last quarter. Integrated Wealth Concepts LLC acquired a new stake in shares of Sabra Healthcare REIT during the 2nd quarter worth $61,000. Finally, NewEdge Advisors LLC increased its holdings in shares of Sabra Healthcare REIT by 261.2% during the 2nd quarter. NewEdge Advisors LLC now owns 71,128 shares of the real estate investment trust's stock worth $1,388,000 after buying an additional 51,435 shares during the last quarter. Hedge funds and other institutional investors own 99.40% of the company's stock.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc is a real estate investment trust that owns and invests in healthcare-related properties. The company primarily focuses on skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals.

Sabra generally leases its properties to healthcare operators under long-term agreements, including triple-net leases, and may provide mortgage loans or other forms of financing to healthcare providers. Its portfolio serves healthcare markets across the United States and Canada.

Founded in 2010 and headquartered in Irvine, California, Sabra became a publicly traded company in 2010.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.